Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre hospitalier de l'Université de Montréal (CHUM)
Psyence Australia Pty Ltd
Daiichi Sankyo
OHSU Knight Cancer Institute
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Elevation Oncology
Xencor, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Exelixis
Universitair Ziekenhuis Brussel
Convalife (Shanghai) Co., Ltd.
Charite University, Berlin, Germany
pharmaand GmbH
M.D. Anderson Cancer Center
OncoNano Medicine, Inc.
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Eli Lilly and Company
University of Iowa
Memorial Sloan Kettering Cancer Center
Bayer
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Center for Complementary and Integrative Health (NCCIH)